Paper17516151
Pharmacodynamic model of interleukin-21 effects on red blood cells in cynomolgus monkeys.
Overgaard RV and 2 others. J Pharmacokinet Pharmacodyn, 2007. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Pharmacodynamic model of interleukin-21 effects on red blood cells in cynomolgus monkeys. Papers, record 17516151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17516151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacodynamic model of interleukin-21 effects on red blood cells in cynomolgus monkeys.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Erythrocytes | Major topic |
| Interleukins | Major topic |
| Models, Biological | Major topic |
| Algorithms | |
| Animals | |
| Antineoplastic Agents | |
| Bilirubin | |
| Blood Cell Count | |
| Blood Volume | |
| Body Weight | |
| Erythrocyte Count | |
| Female | |
| Hemoglobins | |
| Hemolysis | |
| Humans | |
| Macaca fascicularis | |
| Male | |
| Reticulocytes | |
| Interleukin-21 |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10934673 | Mechanism and amelioration of recombinant human interleukin-11 (rhIL-11)-induced anemia in healthy subjects. | J Clin Pharmacol | 2000 | https://conductscience.org/library/papers/10934673 | PubMed |
| 2 | 8360835 | Population pharmacodynamic modeling of drug-induced anemia. | J Pharm Sci | 1993 | https://conductscience.org/library/papers/8360835 | PubMed |
| 3 | 11211153 | Agranulocytosis and hemolytic anemia in patients with renal cell cancer treated with interleukin-12. | J Immunother | 2001 | https://conductscience.org/library/papers/11211153 | PubMed |
| 4 | 10916762 | Autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia and renal cell carcinoma after treatment with high-dose intravenous bolus interleukin-2. | J Immunother | 2000 | https://conductscience.org/library/papers/10916762 | PubMed |
| 5 | 14988424 | Pharmacokinetic/pharmacodynamic analysis of paradoxal regulation of erythropoietin production in acute anemia. | J Pharmacol Exp Ther | 2004 | https://conductscience.org/library/papers/14988424 | PubMed |
| 6 | 11180276 | A good practice guide to the administration of substances and removal of blood, including routes and volumes. | J Appl Toxicol | 2001 | https://conductscience.org/library/papers/11180276 | PubMed |
| 7 | 12518707 | Multiple-pool cell lifespan model of hematologic effects of anticancer agents. | J Pharmacokinet Pharmacodyn | 2002 | https://conductscience.org/library/papers/12518707 | PubMed |
| 8 | 16102948 | Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after multiple subcutaneous doses in healthy subjects. | Eur J Pharm Sci | 2005 | https://conductscience.org/library/papers/16102948 | PubMed |
| 9 | 3228588 | A concept of hemopoietic regulation and its biomathematical realization. | Blood Cells | 1988 | https://conductscience.org/library/papers/3228588 | PubMed |
| 10 | 12458668 | An integrated pharmacodynamic analysis of erythropoietin, reticulocyte, and hemoglobin responses in acute anemia. | Pharm Res | 2002 | https://conductscience.org/library/papers/12458668 | PubMed |
| 11 | 10387489 | Drug-induced hemolytic anemias: increasing complications to therapeutic interventions. | Clin Lab Sci | 1999 | https://conductscience.org/library/papers/10387489 | PubMed |
| 12 | 10992000 | A pharmacodynamic analysis of erythropoietin-stimulated reticulocyte response in phlebotomized sheep. | J Pharmacol Exp Ther | 2000 | https://conductscience.org/library/papers/10992000 | PubMed |
| 13 | 12386637 | Ribavirin dosing in chronic hepatitis C: application of population pharmacokinetic-pharmacodynamic models. | Clin Pharmacol Ther | 2002 | https://conductscience.org/library/papers/12386637 | PubMed |
| 14 | 3427607 | Regulation of recovery in the erythroid lineage: model studies. | Cell Tissue Kinet | 1987 | https://conductscience.org/library/papers/3427607 | PubMed |
| 15 | 12889741 | Pharmacokinetic-pharmacodynamic guided trial design in oncology. | Invest New Drugs | 2003 | https://conductscience.org/library/papers/12889741 | PubMed |
| 16 | 9671330 | Factors influencing quality of life in cancer patients: anemia and fatigue. | Semin Oncol | 1998 | https://conductscience.org/library/papers/9671330 | PubMed |
| 17 | 7632934 | Interleukin-6-associated anemia: determination of the underlying mechanism. | Blood | 1995 | https://conductscience.org/library/papers/7632934 | PubMed |
| 18 | 14657853 | IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses. | J Allergy Clin Immunol | 2003 | https://conductscience.org/library/papers/14657853 | PubMed |
| 19 | 7006823 | A comprehensive mathematical model of stem cell proliferation which reproduces most of the published experimental results. | Cell Tissue Kinet | 1980 | https://conductscience.org/library/papers/7006823 | PubMed |
| 20 | 11081504 | Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. | Nature | 2000 | https://conductscience.org/library/papers/11081504 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40707717 | A semi-mechanistic population pharmacokinetic-pharmacodynamic model to assess downstream drug-target effects on erythropoiesis. | J Pharmacokinet Pharmacodyn | 2025 | https://conductscience.org/library/papers/40707717 | PubMed |
| 22022259 | An integrated disease/pharmacokinetic/pharmacodynamic model suggests improved interleukin-21 regimens validated prospectively for mouse solid cancers. | PLoS Comput Biol | 2011 | https://conductscience.org/library/papers/22022259 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL21 | 59067 | PubTator's text mining | https://conductscience.org/library/genes/59067 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17516151
GET https://conductscience.org/api/papers/v1/17516151/references?page=2